Publication
Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques
Downloadable Content
- Persistent URL
- Last modified
- 05/14/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2020-11-25
- Publisher
- CELL PRESS
- Publication Version
- Copyright Statement
- © 2020 Elsevier Inc.
- Final Published Version (URL)
- Title of Journal or Parent Work
- Volume
- 183
- Issue
- 5
- Start Page
- 1354
- End Page
- +
- Grant/Funding Information
- We acknowledge support from the Ragon Institute of MGH, MIT and Harvard; Mark and Lisa Schwartz Foundation; Beth Israel Deaconess Medical Center; Massachusetts Consortium on Pathogen Readiness (MassCPR); Bill & Melinda Gates Foundation (INV-006131); and the National Institutes of Health (OD024917, CA260476, AI124377, AI126603, AI128751, AI129797, and AI149670). The Yerkes Genomics Core is supported in part by NIH P51 OD011132, and sequencing data were acquired on an Illumina NovaSeq6000 funded by NIH S10 OD026799.
- Abstract
- Aid et al. show that SARS-CoV-2 causes endothelial disruption and vascular thrombosis in both human and rhesus macaques lungs by inducing an upregulation of proinflammatory cytokines. Using an approach that combines histopathology and multiomics in macaques, they show the progression to vascular disease over time, which involves complement, macrophage, cytokine, and thrombosis cascades.
- Author Notes
- Keywords
- Research Categories
- Biology, Cell
- Biology, Molecular
- Chemistry, Biochemistry
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - vqgb4.pdf | Primary Content | 2025-05-01 | Public | Download |